Eli Lilly & Co. (LLY)
1144.03
-5.12
(-0.45%)
USD |
NYSE |
Jun 09, 16:00
1144.44
+0.41
(+0.04%)
After-Hours: 16:14
Eli Lilly Research and Development Expense (Quarterly) : 3.51B for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Johnson & Johnson | 3.495B |
| Merck & Co., Inc. | 11.98B |
| Pfizer Inc. | 2.452B |
| Bristol Myers Squibb Co. | 2.238B |
| Structure Therapeutics, Inc. | 66.71M |